Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/1999
08/10/1999CA2098593C Treatment method for cancer
08/10/1999CA2093434C Regulation of immunoglobulin production by interleukin-9
08/10/1999CA1340704C Human interferon-gamma, process to prepare said human interferon-gamma, and its use
08/10/1999CA1340703C Production of insulin-like growth factor binding protein
08/09/1999CA2260701A1 Method of preparing substituted quinazolin-4-ones
08/05/1999WO1999038998A1 Methods of identifying modulators of kinases responsive to stress
08/05/1999WO1999038983A1 Novel sphingosine-1 phosphate lyase
08/05/1999WO1999038889A2 Modulation of sodium channels in dorsal root ganglia
08/05/1999WO1999038882A1 Human cystatin f
08/05/1999WO1999038881A1 67 human secreted proteins
08/05/1999WO1999038873A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999WO1999038870A1 Compounds containing boron for electron microscopy and for boron neutron-capture therapy
08/05/1999WO1999038868A1 Azolo triazines and pyrimidines
08/05/1999WO1999038864A1 Oxazole derivatives as serotonin-1a receptor agonists
08/05/1999WO1999038863A1 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
08/05/1999WO1999038862A1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
08/05/1999WO1999038854A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999WO1999038853A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
08/05/1999WO1999038850A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
08/05/1999WO1999038845A1 Ppar-gamma modulators
08/05/1999WO1999038841A1 Adamantanecarboximidamide derivatives and their use as nmda antagonists
08/05/1999WO1999038536A1 Absorbable microparticles
08/05/1999WO1999038534A1 Neurotrophic factor secretion promoters
08/05/1999WO1999038523A1 CYTOKINE INDUCERS COMPRISING M161Ag
08/05/1999WO1999038514A1 Cyclic amine modulators of chemokine receptor activity
08/05/1999WO1999038510A1 Derivatives of 1,3,4-oxadiazolone
08/05/1999WO1999038501A2 Method of regulating glucose metabolism, and reagents related thereto
08/05/1999WO1999028493A3 Method for identifying inhibitors of g-protein coupled receptor hibef51
08/05/1999WO1999021860B1 Phenanthroline derivatives
08/05/1999WO1999020643A9 Using polyamide nucleic acid oligomers to engender a biological response
08/05/1999WO1999020121A9 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue
08/05/1999WO1997010824A8 Use of 5ht1b receptor antagonist for the treatment of vascular disease
08/05/1999DE19804251A1 Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Biphenylsulfonylcyanamide, processes for their preparation and their use as a medicament
08/05/1999CA2819705A1 Method of regulating glucose metabolism, and reagents related thereto
08/05/1999CA2755452A1 Method of regulating glucose metabolism, and reagents related thereto
08/05/1999CA2319781A1 Cyclic amine modulators of chemokine receptor activity
08/05/1999CA2319629A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
08/05/1999CA2319387A1 Neurotrophic factor secretion promoters
08/05/1999CA2319195A1 Method of regulating glucose metabolism, and reagents related thereto
08/05/1999CA2319143A1 Modulation of sodium channels in dorsal root ganglia
08/05/1999CA2319129A1 67 human secreted proteins
08/05/1999CA2319081A1 Human cystatin f
08/05/1999CA2318830A1 Derivatives of 1,3,4-oxadiazolone
08/05/1999CA2318817A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999CA2318814A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999CA2318152A1 Absorbable microparticles
08/05/1999CA2317515A1 Oxazole derivatives as serotonin-1a receptor agonists
08/05/1999CA2317459A1 Methods of identifying modulators of kinases responsive to stress
08/05/1999CA2313226A1 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
08/04/1999EP0933380A1 Method of searching for physiologically active substances and process for producing the same
08/04/1999EP0933373A1 Terpenoid lactone compounds and their production process
08/04/1999EP0933372A1 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
08/04/1999EP0933367A1 Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists
08/04/1999EP0933366A1 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
08/04/1999EP0933351A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0933350A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0932701A1 STRUCTURAL AND FUNCTIONAL CONSERVATION OF THE C. ELEGANS CLOCK GENE clk-1
08/04/1999EP0932686A2 Telomerase reverse transcriptase
08/04/1999EP0932678A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
08/04/1999EP0932675A2 Epidermal differentiation factor
08/04/1999EP0932674A1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES
08/04/1999EP0932609A1 AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO 2,3-e]INDOL-8-ONE
08/04/1999EP0932606A1 Inhibitors of prenyl transferases
08/04/1999EP0932598A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
08/04/1999EP0932420A1 Drug delivery using terminal complement components
08/04/1999EP0932406A1 Methods of treating or preventing interstitial cystitis
08/04/1999EP0932402A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
08/04/1999EP0932399A1 Water soluble paclitaxel prodrugs
08/04/1999EP0759027B1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
08/04/1999EP0752985B1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
08/04/1999EP0744957B1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/04/1999EP0740653B1 Hydroxamic acid derivatives as metalloproteinase inhibitors
08/04/1999EP0701555B1 Indazole derivatives
08/04/1999EP0665739B1 Morphogen-induced periodontal tissue regeneration
08/04/1999EP0640086B1 MERCAPTOACETYLAMIDO PYRIDAZO[ 1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
08/04/1999EP0628038B1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO [b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION
08/04/1999EP0585242B1 Wound healing
08/04/1999CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors
08/04/1999CN1225082A Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
08/04/1999CN1224720A Tetracylic derivatives, process of preparation and use
08/04/1999CN1224718A Thiazole derivatives
08/04/1999CN1224714A N-(4-carbamimido-phenyl)-phenylglycinamid derivatives
08/03/1999US5932765 Nitromethyl ketones, process for preparing them and compositions containing them
08/03/1999US5932749 Asymmetric synthesis of R-α-propyl-piperonyl amine and its analogs
08/03/1999US5932737 Peptide compounds for treatment of no-mediated diseases
08/03/1999US5932734 N-aminoalkylfluorenecarboxamides
08/03/1999US5932726 Asymmetric synthesis of benzoxazinones
08/03/1999US5932716 Disclosed herein are methods and compositions for identifying morphogen analogs.
08/03/1999US5932703 The present invention provides purified and isolated polynucleotide sequences encoding a novel human macrophage-derived c--c chemokine designated mdc, and polypeptide analogs thereof.
08/03/1999US5932701 ribA
08/03/1999US5932616 Potent inducers of terminal differentiation and methods of use thereof
08/03/1999US5932610 Tumor necrosis factor α (TNF-α) inhibiting pharmaceuticals
08/03/1999US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors
08/03/1999US5932595 Antiarthritic agent; multiple sclerosis; osteoporosis; respiratory system disorders; skin disorders; antiulcer agent
08/03/1999US5932593 Antiserotonin agent
08/03/1999US5932586 Prostaglandin synthase inhibitors
08/03/1999US5932581 Administering sorbitol dehydrogenase inhibitor
08/03/1999US5932580 PDGF receptor kinase inhibitory compounds their preparation and compositions
08/03/1999US5932576 3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
08/03/1999US5932574 Anticancer agent
1 ... 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 ... 1564